Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

about

Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model.Direct acting oral anticoagulant: Bench to bedside.

P2860

Q39129273-1F321A3A-2DE7-478E-8B28-1407C2AEECB2 Q55361115-86C399E3-14D2-4344-B8A9-4CFC7BC4F59C Q55692305-0F32F50D-FC58-45F5-84F9-DC1DE9F43595

P2860

Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

Item

http://www.wikidata.org/entity/Q38878032

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

@en

type

Item

label

Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

@en

prefLabel

Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

@en

P1476

Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

@en

P2093

Anand Patel

http://www.w3.org/2001/XMLSchema#string

Nils Henninger

http://www.w3.org/2001/XMLSchema#string

Richard P Goddeau

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

A specific antidote for dabigatran: functional and structural characterization

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Edoxaban versus warfarin in patients with atrial fibrillation

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants.

P304

94-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874192401610010094

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27347226

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

4897006

http://www.w3.org/2001/XMLSchema#string

Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

about

P2860

P2860

Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932